Skip to main content

Rheumatology Therapeutics Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

 


Rheumatology is a branch of medicine dedicated to the diagnosis and therapy of rheumatic diseases. Rheumatology therapeutics involve physical therapies, exercises, and medications with surgical treatment to cure joint damage. Scleroderma, fibromyalgia, gout, osteoarthritis, reactive arthritis, psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis are some common types of rheumatology diseases. Thus, with the increasing burden of rheumatology diseases worldwide, the demand for rheumatology therapeutics is also increasing. According to the Centers for Disease Control and Prevention (CDC), by 2040, around 78 million adults in the United States aged 18 years or older are expected to have doctor-diagnosed arthritis.

The aforementioned factors are expected to augment the rheumatology therapeutics market growth. Moreover, doctors prescribe disease-modifying antirheumatic drugs (DMARDs) for the treatment of rheumatologic disease. For example, in April 2021, Nēsos received the United States Food and Drug Administration (FDA) Breakthrough Device Designation to its digital therapeutic for patients with rheumatoid arthritis (RA) who have had an inadequate response or intolerance to DMARDs. Furthermore, in March 2021, American Rheumatology Network (ARN) launched ARN Clinical Research, a patient centric and real-world technology unit for transforming rheumatology trials and care.

Regional segmentation of rheumatology therapeutics market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominates rheumatology therapeutics market, owing to increasing population with rheumatology diseases, changing lifestyle, and established medical and healthcare sector.

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...
Post a Comment
Read more